Extavia vs Rebif

Extavia
(Rx)
Rebif
(Rx)
Extavia is a multiple sclerosis medication.
Rebif is a multiple sclerosis medication.
Satisfaction Score
?
2.6
Slightly Satisfied
Satisfaction Score
?
2.4
Slightly Satisfied
Helpfulness
for MS
2.3
Concern level
2.2
Approval Date
+ -
August 14, 2009
March 7, 2002
Number of discussions around the web Number of discussions + -
462 Discussions
30,592 Discussions
Taken For
+ -
Condition
Number of posts
#1 for MS
#2 for RRMS
#3 for SPMS
#4 for CIS
Extavia is prescribed for MS and is mostly mentioned together with this indication.
Condition
Number of posts
#1 for MS
#2 for RRMS
#3 for SPMS
Rebif is prescribed for MS and is mostly mentioned together with this indication.
Side Effects and Concerns
+ -
Ext
Flu Like Symptoms
8
Tiredness
6
Depression
5
Flu
3
Injection Site Reactions
3
Welts
2
Flu Symptoms
2
Headaches
2
Insomnia
2
Irritability
1
Reb
Tiredness
10
Flu Like Symptoms
8
Depression
7
Headaches
5
Flu
3
Bruise
3
Allergy
3
Itching
2
Anxiety
2
Fever
2
Compare concerns
By:
Extavia
Ext
Rebif
Reb
Flu Like Symptoms
Ext
Reb
8
8
Tiredness
Ext
Reb
6
10
Depression
Ext
Reb
5
7
Flu
Ext
Reb
3
3
Injection Site Reactions
Ext
Reb
3
0
Welts
Ext
Reb
2
0
Flu Symptoms
Ext
Reb
2
0
Headaches
Ext
Reb
2
5
Insomnia
Ext
Reb
2
0
Irritability
Ext
Reb
1
0
Tiredness
Reb
Ext
10
6
Flu Like Symptoms
Reb
Ext
8
8
Depression
Reb
Ext
7
5
Headaches
Reb
Ext
5
2
Flu
Reb
Ext
3
3
Bruise
Reb
Ext
3
0
Allergy
Reb
Ext
3
0
Itching
Reb
Ext
2
0
Anxiety
Reb
Ext
2
0
Fever
Reb
Ext
2
0
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
C Category C
Before taking Extavia during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
C Category C
Before taking Rebif during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Alcohol warning
+ -
There may be a negative interaction between Extavia and alcohol.
There may be a negative interaction between Rebif and alcohol.
Method of use
+ -
Injection
Injection
Dosages
+ -
Kit: 0.3 mg
Solution: 0.3 mg
Syringe: 22 mcg/0.5 mL, 44 mcg/0.5 mL
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Interferon Beta-1b
Interferon Beta-1a/Albumin Human, Interferon Beta-1a
Drug Interactions
+ -
Interaction between Extavia and Rebif: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
Extavia
Read more about:
Rebif
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 118 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...